Posts Tagged ‘EHR’

A key challenge to making full use of your Patient Satisfaction Survey Data is learning how to integrate it with your EHR data. Having an understanding of a patient’s associated encounters can provide valuable context on the results you receive on a Patient Satisfaction Survey. The challenge oftentimes is having the right data to link […]

I just got back from the doctor whose office is in one of the leading hospitals in the United States. I was his first appointment of the day. “They just updated Epic this morning, and everyone is getting into the office trying to make sense of the changes,” the doctor said. I asked if he […]

Researchers with the U.S. Army claim that clinical data visualization is a key component in the usage and delivery of EHRs because it: Presents data in a pleasing, easy-to-understand manner Makes digesting and sharing data faster and simpler Reduces the time needed to interpret and understand data points Increases the user’s ability to see trends […]

Healthcare IT is ever-changing and Perficient is on the forefront of this change, guiding the industry and those we serve toward a brighter future. We partner with healthcare companies to help people live their lives to their fullest potential today, using best practices and cost saving technologies and processes. As we look to the future […]

Exposing patient health information as Application Program Interfaces (APIs) is one of the most critical components in Stage 3 of the EHR Incentive Programs and all providers will be required to comply with MU3 requirements by 2018. The APIs will ensure improved patient engagement by providing data access in application of patient’s choice instead of […]

We’ve talked a lot in this blog about the use of electronic health records (EHRs) in clinical trials. Recently, my colleague wrote about it on our healthcare blog, so, I thought I would share her post with my pharma and CRO friends. While our previous posts focused on the use of EHR for subject recruitment […]

The Food and Drug Administration has issued a draft guidance stating that in order to see the highest success, clinical trial leaders must use electronic health records (EHR) that promote health data interoperability. In the draft guidance entitled Use of Electronic Health Record Data in Clinical Investigations, the FDA indicated that health data interoperability may […]

In our next 2016 Connected Health trend we find ourselves with the call from patient advocates around the land: increased ownership of data by the patient. The healthcare industry is the guardian of, in my opinion, the world’s most important data. With that being true, the patient data guardianship story is about to get even […]

  Real-world data, the data generated about drugs and devices in real-world settings (e.g., routing doctor visits, hospital stays, etc.), can help develop more accurate product profiles. This is because the data comes from products that are no longer confined to the smaller, homogenous populations involved in clinical trials. More comprehensive profiles can help better […]

  Patients who are being treated for diseases, such as cancer, often require multiple drugs to manage their conditions. For example, patients are often prescribed drugs that treat the actual disease, while others are meant to manage side effects from those drugs. Many of these patients can probably attest to inquiring about or doing their […]

  According to an article in Clinical Leader that featured Bayer Healthcare’s VP Global Strategy & Development Advisor, by evaluating certain criteria against patient populations, electronic health record (EHR) systems can help sponsors determine trial feasibility and shape better study protocols. This can reduce the number of amendments, which can cost anywhere from $300,000 to […]

  Recruiting subjects for clinical trials has been a longstanding challenge for pharmaceutical and research organizations. According to Dr. Steven Alberts, Chair of Medical Oncology with the Mayo Clinic, only 5% of cancer patients ever enroll in a trial. On top of that, only a fraction of all trials ever finish enrolling enough patients on […]